These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28166725)

  • 1. Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial.
    Maikranz V; Siebenhofer A; Ulrich LR; Mergenthal K; Schulz-Rothe S; Kemperdick B; Rauck S; Pregartner G; Berghold A; Gerlach FM; Petersen JJ
    BMC Fam Pract; 2017 Feb; 18(1):15. PubMed ID: 28166725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices - results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment).
    Mertens C; Siebenhofer A; Berghold A; Pregartner G; Ulrich LR; Mergenthal K; Kemperdick B; Schulz-Rothe S; Rauck S; Harder S; Gerlach FM; Petersen JJ
    BMC Health Serv Res; 2019 Aug; 19(1):539. PubMed ID: 31370840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice nursed-based, individual and video-assisted patient education in oral anticoagulation--protocol of a cluster-randomized controlled trial.
    Hua TD; Vormfelde SV; Abu Abed M; Schneider-Rudt H; Sobotta P; Friede T; Chenot JF
    BMC Fam Pract; 2011 Apr; 12():17. PubMed ID: 21477372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
    Vinereanu D; Lopes RD; Bahit MC; Xavier D; Jiang J; Al-Khalidi HR; He W; Xian Y; Ciobanu AO; Kamath DY; Fox KA; Rao MP; Pokorney SD; Berwanger O; Tajer C; de Barros E Silva PGM; Roettig ML; Huo Y; Granger CB;
    Lancet; 2017 Oct; 390(10104):1737-1746. PubMed ID: 28859942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
    Baker JW; Pierce KL; Ryals CA
    J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.
    Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U
    Thromb Haemost; 2007 Mar; 97(3):408-16. PubMed ID: 17334508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
    Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
    Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial.
    Clarkesmith DE; Pattison HM; Lip GY; Lane DA
    PLoS One; 2013; 8(9):e74037. PubMed ID: 24040156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supporting anticoagulant treatment decision making to optimise stroke prevention in complex patients with atrial fibrillation: a cluster randomised trial.
    Gattellari M; Hayen A; Leung DYC; Zwar NA; Worthington JM
    BMC Fam Pract; 2020 Jun; 21(1):102. PubMed ID: 32513116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation with vitamin K inhibitors and determinants of successful self-management in primary care.
    Tamayo Aguirre E; Galo-Anza A; Dorronsoro-Barandiaran O; Del Burgo EU; Ostiza Irigoyen A; Garcia-Carro A; Lopez-Fernandez I; Colera N; Saez-Garbayo P; Tamayo-Uria I
    BMC Cardiovasc Disord; 2016 Sep; 16(1):180. PubMed ID: 27624485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
    Lee YJ; Park JK; Uhm JS; Kim JY; Pak HN; Lee MH; Sung JH; Joung B
    Int J Cardiol; 2016 Jan; 203():372-8. PubMed ID: 26539960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events.
    Alphonsa A; Sharma KK; Sharma G; Bhatia R
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):668-72. PubMed ID: 25577429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
    Kirchhof P; Blank BF; Calvert M; Camm AJ; Chlouverakis G; Diener HC; Goette A; Huening A; Lip GYH; Simantirakis E; Vardas P
    Am Heart J; 2017 Aug; 190():12-18. PubMed ID: 28760205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.
    Verret L; Couturier J; Rozon A; Saudrais-Janecek S; St-Onge A; Nguyen A; Basmadjian A; Tremblay S; Brouillette D; de Denus S
    Pharmacotherapy; 2012 Oct; 32(10):871-9. PubMed ID: 23033226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial.
    Ashburner JM; Atlas SJ; Khurshid S; Weng LC; Hulme OL; Chang Y; Singer DE; Ellinor PT; Lubitz SA
    J Gen Intern Med; 2018 Dec; 33(12):2070-2077. PubMed ID: 30076573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial.
    Claes N; Buntinx F; Vijgen J; Arnout J; Vermylen J; Fieuws S; Van Loon H
    Eur Heart J; 2005 Oct; 26(20):2159-65. PubMed ID: 15917280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.